Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-23

Clinical Trial Update: A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 4% chlorhexidine to methylated spirit for prophylaxis of omphalitis and neonatal sepsis; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 4% chlorhexidine (chlorhexidine)
  • methylated spirit (ethyl alcohol mixed with methanol)

Snippet

Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute | Conditions: Neonatal Sepsis, Omphalitis | Phase 2 | Status: COMPLETED